Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series

Publication date

2022-01-28

Authors

Albshesh, Ahmad
Eder, Piotr
Ribaldone, Davide Giuseppe
Oldenburg, BasISNI 0000000387307453
de Boer, Nanne K
Mantzaris, Gerassimos J
Savarino, Edoardo Vincenzo
Dragoni, Gabriele
Weisshof, Roni
Truyens, Marie

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

BACKGROUND: Hypogammaglobulinaemia is a disorder characterized by low serum immunoglobulin levels and a high prevalence of gastrointestinal manifestations. In some cases, clinical and endoscopic features are indistinguishable from those of inflammatory bowel disease [IBD]. METHODS: This was a multicentre case series performed as a part of the European Crohn's and Colitis Organisation [ECCO] Collaborative Network of Exceptionally Rare case reports [CONFER] project. RESULTS: This report includes 27 patients with primary hypogammaglobulinaemia and IBD-like features: 20 males and seven females, median age 45.6 years (interquartile range [IQR] 35.2-59). Crohn's disease-like features were noted in 23 patients, and four patients had ulcerative colitis-like features. The diagnosis of hypogammaglobulinaemia preceded a diagnosis of IBD-like features in 20 patients [median of 7 years prior, IQR 2.6-20.6 years], and followed the appearance of IBD-like features in seven cases [median of 1 year after, IQR 0.45-5.6 years]. Hypogammaglobulinaemia aetiologies were common variable immunodeficiency [66.6%], agammaglobulinaemia [7.4%], selective IgA-deficiency [11.1%], Good's syndrome [7.4%], IgG subclass deficiency with IgA deficiency [3.7%] and hyper-IgM [3.7%]. In addition to antibiotics and intravenous immunoglobulin [IVIG] for hypogammaglobulinaemia, 12 patients received IBD-related treatment including 5-aminosalicylate agents [two patients], corticosteroids [one patient], thiopurines [three patients], anti-tumour necrosis factor [four patients] and vedolizumab [two patients]. By the end of the follow-up (44.5 months [IQR 18-81]), 21/27 [77%] patients were in clinical remission. CONCLUSION: This case series describes IBD-like features in patients with hypogammaglobulinaemia. The diagnosis of IBD-like features mainly occurred after that of hypogammaglobulinaemia, with successful recovery in the majority of cases after appropriate treatment.

Keywords

IBD-like features, Primary hypogammaglobulinaemia, immunodeficiency, inflammatory bowel disease, Taverne, Gastroenterology

Citation

Albshesh, A, Eder, P, Ribaldone, D G, Oldenburg, B, de Boer, N K, Mantzaris, G J, Savarino, E V, Dragoni, G, Weisshof, R, Truyens, M, Festa, S, Maillard, M H, Capirchio, L, Filip, R, Theodoraki, E & Kopylov, U 2022, 'Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features : An ECCO CONFER Multicentre Case Series', Journal of Crohn's & Colitis, vol. 16, no. 1, pp. 91-97. https://doi.org/10.1093/ecco-jcc/jjab124